NWS
83
2
NSC
62
-3
SWK
62
-3
OI
45
-5
DE
38
-4
EXR
55
-5
YUM
48
-2
PEG
60
-2
WAT
65
4
CME
61
2
CMG
72
5
STZ
55
2
AXP
69
-2
MCD
59
-3
LUV
47
-2
AA
38
-18
PSA
53
-7
CMA
62
-5
LYB
37
-2
ABT
60
-2
NWS
83
2
NSC
62
-3
SWK
62
-3
OI
45
-5
DE
38
-4
EXR
55
-5
YUM
48
-2
PEG
60
-2
WAT
65
4
CME
61
2
CMG
72
5
STZ
55
2
AXP
69
-2
MCD
59
-3
LUV
47
-2
AA
38
-18
PSA
53
-7
CMA
62
-5
LYB
37
-2
ABT
60
-2
Financhill
Back

Relay Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
49

RLAY
Relay Therapeutics

Last Price:
5.82
Seasonality Move:
2.51%
Buy
60

BMRN
Biomarin Pharmaceutical

Last Price:
66.65
Seasonality Move:
13.04%
Sell
49
Relay Therapeutics (RLAY) is a Sell

Is Relay Therapeutics a Buy, Sell or Hold?

  • The current Relay Therapeutics [RLAY] share price is $5.94. The Score for RLAY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • RLAY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $66.12. The Score for BMRN is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

RLAY Stock Price Chart

What is Relay Therapeutics's stock price today?

  • The Relay Therapeutics share price today is $5.94
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing selling pressure, which indicates risk of future bearish movement.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $66.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing slight selling pressure.

RLAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 41.54 Sell
Chaikin Money Flow: -849788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.9 - 6.6) Sell
Bollinger Bands (100): (6.14 - 7.98) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 33.22 Sell
Chaikin Money Flow: -314047 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.74 - 70.42) Sell
Bollinger Bands (100): (70.34 - 87.98) Sell

RLAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.04 Sell
20-day SMA: 6.17 Sell
50-day SMA: 6.76 Sell
200-day SMA: 7.48 Sell
8-day EMA: 6.06 Sell
20-day EMA: 6.19 Sell
50-day EMA: 6.57 Sell
200-day EMA: 7.67 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.41 Sell
20-day SMA: 68.28 Sell
50-day SMA: 72.14 Sell
200-day SMA: 82.07 Sell
8-day EMA: 66.71 Sell
20-day EMA: 68.01 Sell
50-day EMA: 72.04 Sell
200-day EMA: 80.69 Sell

Relay Therapeutics Earnings Growth & RLAY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.

Relay Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):